Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention

Vaginal tablets are being developed as an alternative to gels as an inexpensive, discreet dosage form for the administration of microbicides. This work describes the pharmacokinetic (PK) evaluation of rapidly disintegrating vaginal tablets containing tenofovir (TFV, 10 mg), emtricitabine (FTC, 10 mg...

Full description

Bibliographic Details
Main Authors: Meredith R. Clark, M. Melissa Peet, Sarah Davis, Gustavo F. Doncel, David R. Friend
Format: Article
Language:English
Published: MDPI AG 2014-12-01
Series:Pharmaceutics
Subjects:
Online Access:http://www.mdpi.com/1999-4923/6/4/616